DERIVATIVES OF PHENYLAMINOIMIDAZOLINE OR PHENYLIMINOIMIDAZOLIDINE ELICITIN G WITH PROPERTY OF AGONIST OF alpha1L-ADRENOCEPTORS AND PHARMACEUTICAL COMPOSI TION BASED ON THEREOF

FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention proposes new derivatives of phenylaminoimidazoline or phenyliminoimidazolidine of the general formula (Ib) alpha1L or (II) , respectively. Radical values are given in the invention claim. Indicated isomers by a double bond elicit the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	EHSSER FRANTS, LJUTTKE SVEN, UCHIDA SHUJU, MURUMATSU IKUNOBU, SHTELE KHEL'MUT, KITAGAVA KHISATO
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention proposes new derivatives of phenylaminoimidazoline or phenyliminoimidazolidine of the general formula (Ib) alpha1L or (II) , respectively. Radical values are given in the invention claim. Indicated isomers by a double bond elicit the property of agonist of -adrenoceptors. Also, invention proposes a pharmaceutical composition based on thereof. EFFECT: expanded assortment of agents of indicated designation, valuable medicinal properties of compounds. 7 cl, 1 tbl, 4 ex